Yahoo
OTC Markets OTCQB - Delayed Quote USD

InVitro International, Inc. (IVRO)

0.0679 0.0000 (0.00%)
At close: August 10 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for IVRO
  • Previous Close 0.0679
  • Open 0.0611
  • Bid 0.0455 x 1820000
  • Ask 0.0515 x 1000000
  • Day's Range 0.0500 - 0.0611
  • 52 Week Range 0.0315 - 0.1600
  • Volume 53,215
  • Avg. Volume 1,249
  • Market Cap (intraday) 1.511M
  • Beta (5Y Monthly) -0.83
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.

www.invitrointl.com

--

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 8/11/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IVRO
24.56%
S&P 500 (^GSPC)
12.89%

1-Year Return

IVRO
11.59%
S&P 500 (^GSPC)
21.26%

3-Year Return

IVRO
6.34%
S&P 500 (^GSPC)
73.12%

5-Year Return

IVRO
53.49%
S&P 500 (^GSPC)
73.96%

Statistics

View More

Valuation Measures

Annual
As of 8/10/2026
  • Market Cap

    1.51M

  • Enterprise Value

    548.16k

  • Trailing P/E

    16.98

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.88

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    0.66

  • Enterprise Value/EBITDA

    6.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.15%

  • Return on Assets (ttm)

    2.45%

  • Return on Equity (ttm)

    7.06%

  • Revenue (ttm)

    811.29k

  • Net Income Avi to Common (ttm)

    106.7k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    332.67k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    57.67k

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: